Voxelotor Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 500 mg
Reference Brands: Oxbryta(US)
Category: Blood Disorder
Voxelotor tablets is available in Tablet and strengths such as 500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Voxelotor tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Voxelotor tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Voxelotor, marketed as Oxbryta, is approved in the US by the FDA for treating sickle cell disease. In the EU, regulatory approval is pending or under review. Approval requires a comprehensive dossier including clinical trial data, safety, efficacy, pharmacovigilance, and manufacturing details. In the US, submission involves detailed clinical study review, while the EU follows EMA guidelines for authorization. For guidance on dossier preparation, regulatory pathways, and successful market entry strategies, visit PharmaTradz. Ensuring compliance with regional regulations is essential for the safe, approved, and effective use of voxelotor worldwide, supporting patients with sickle cell disease.
Frequently Asked Questions
Related Products
Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder
Strength:
500 units, 1000 units, and 2500 units
Form: Lyophilized Powder (Reconstituted for IV infusion)
Reference Brands: FEIBA(US)
View Details
Prothrombin Complex Concentrate (Pcc) Injection
Strength:
250 IU to 300 IU
Form: Injection
Reference Brands: Kcentra (4-factor PCC), Bebulin VH (3-factor PCC)(US)
View Details
Leucovorin Tablets/Capsule
Strength:
15 mg, 50 mg
Form: Tablet/Capsules
Reference Brands: Folvite(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
